title: Resolution of refractory uveitis, switching anti-TNF treatment.
authors.forename: Senen
authors.initials: S
authors.lastname: González-Suárez
authors.forename: Edilia
authors.initials: E
authors.lastname: Garcia-Fernandez
authors.forename: Roberto
authors.initials: R
authors.lastname: Martinez-Rodriguez
authors.forename: Rita
authors.initials: R
authors.lastname: de la Cruz-Kuhnel
authors.forename: Carmen
authors.initials: C
authors.lastname: Ordás-Calvo
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014605:Uveitis / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab